Tower Research Capital (TRC)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Sell
21,432
-18,763
-47% -$4.98M 0.25% 59
2026
Q1
$4.41M Buy
40,195
+14,694
+58% +$2.09M 0.11% 169
2025
Q4
$4.24M Buy
25,501
+24,952
+4,545% +$4.17M 0.1% 175
2025
Q3
$107K Sell
549
-1,937
-78% -$319K ﹤0.01% 1929
2025
Q2
$225K Buy
2,486
+2,076
+506% +$164K 0.01% 1667
2025
Q1
$24.5K Sell
410
-3,066
-88% -$284K ﹤0.01% 2780
2024
Q4
$460K Buy
3,476
+1,587
+84% +$149K 0.01% 1128
2024
Q3
$99K Sell
1,889
-13,111
-87% -$615K ﹤0.01% 2238
2024
Q2
$908K Buy
15,000
+14,593
+3,586% +$1.01M 0.02% 839
2024
Q1
$30.2K Buy
+407
New +$30.2K ﹤0.01% 2646

Other funds holding ALAB

Tower Research Capital (TRC)'s ALAB Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Astera Labs (ALAB) stake by 47% in Q2 2026, selling an estimated $4.98M and leaving 21,432 shares worth $10.4M. The position accounts for 0.25% of the portfolio, ranked #59.

Tower Research Capital (TRC) first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Tower Research Capital (TRC) held 21,432 shares of Astera Labs worth $10.4M as of Q2 2026.
  • Tower Research Capital (TRC) sold 18,763 Astera Labs shares in Q2 2026, an estimated $4.98M.
  • Astera Labs made up 0.25% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #59 holding.
  • Tower Research Capital (TRC) first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.